Open Access

Serological, clinical and epidemiological aspects of Lyme borreliosis in Mures County, Romania


Cite

1. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: clinical case definition for diagnosis and management in Europe. Clin Microbiol Infect. 2011 Jan;17(1):69-79 DOI: 10.1111/j.1469-0691.2010.03175.x10.1111/j.1469-0691.2010.03175.x20132258Search in Google Scholar

2. Wright WF, Riedel DJ, Talwani R, Gilliam BL. Diagnosis and Management of Lyme disease. Am Fam Physician. 2012 Jun 1; 85(11):1086-93Search in Google Scholar

3. Wormser GP, Brisson D, Liveris D, Hanincora K, Sandigursky S, et al. Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis. 2008 Nov 1;198(9):1358-64 DOI: 10.1086/59227910.1086/592279277673418781866Search in Google Scholar

4. Wormser GP, Dattwyler RJ, Shapirro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006 Nov 1;43(9):1089-134 DOI: 10.1086/50866710.1086/50866717029130Search in Google Scholar

5. Coipan EC, Vladimirescu AF: Ixodes ricinus ticks (Acari: Ixodidae): vectors for Lyme disease spirochetes in Romania. Exp Appl Acarol. 2011 Jul;54(3):293-300 DOI: 10.1007/s10493-011-9438-410.1007/s10493-011-9438-421431930Search in Google Scholar

6. Lindgren E, Jaenson TGT: Lyme borreliosis in Europe. Influences of climate and climate change, epidemiology, ecology and adaptation measures, World Health Organization, Regional Office for Europe, Copenhagen, Denmark. 2006;5-24 [http://www.euro.who.int/__data/ assets/pdf_file/0006/96819/E89522.pdf]Search in Google Scholar

7. European Concerted Action on Lyme Borreliosis. Diagnosis: Case Definition EUCALB: [http://eucalb.com/]Search in Google Scholar

8. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol. 2007;49(1):13-21. Review DOI: 10.1111/j.1574-695X.2006.00139.x10.1111/j.1574-695X.2006.00139.x17266710Search in Google Scholar

9. Centrul Național de Supraveghere şi Control al Bolilor Transmisibile - Boala Lyme - metodologie de supraveghere: Lyme borreliosis. [http://www.insp.gov. ro/cnscbt/index.php?option=com_docman&task=cat_ view&gid=34&Itemid=10] [in Romanian]Search in Google Scholar

10. Centers for Disease Control and Prevention United States: Effect of electronic laboratory reporting on the burden of Lyme disease surveillance: New Jersey, 2001-2006. MMWR. 2008 Jan;57(2):42-5Search in Google Scholar

11. Hristea A, Hristescu S, Ciufecu C, Vasile A: Seroprevalence of Borrelia burgorferi in Romania. Eur J Epidemiol. 2001;17(9):891-6 DOI: 10.1023/A:101560072990010.1023/A:1015600729900Search in Google Scholar

12. Semenza JC, Suk JE, Estevez V, Ebi KL, Lindgren E. Mapping Climate Change Vulnerabilities to Infectious Disease in Europe. Environ Health Perspect. 2012 Mar;120(3):385-92 DOI: 10.1289/ehp.110380510.1289/ehp.1103805329534822113877Search in Google Scholar

13. Stanek G, Strle F. Lyme borreliosis: a European perspective ondiagnosis and clinical management. Curr Opin Infect Dis. 2009 Oct;22(5):450-4 DOI: 10.1097/ QCO.0b013e32832ee88010.1097/QCO.0b013e32832ee88019571749Search in Google Scholar

14. Rizzoli A, Hauffe HC, Carpi G, Vourch GI, Neseler M, Rosa R. Lyme borreliosis in Europe. Eurosurveillance. 2011 Jul;16(27):1-610.2807/ese.16.27.19906-enSearch in Google Scholar

15. Halperin JJ, Shapiro ED, Logigian EL, Belman AL, Dotevall L, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007 Jul;69(1):91-102 DOI: 10.1212/01. wnl.0000265517.66976.28Search in Google Scholar

16. Țilea B, Chiriac C, Țilea I, Urcan R, Tripon G, Gliga M. Diagnostic, therapeutic and evolutive particularities of Lyme disease. Rev Romana Med Lab. 2009 Jun;15(2):55-60Search in Google Scholar

17. O’Connel S. Lyme borreliosis: current issues in diagnosis and management. Curr Opin Infect Dis. 2010 Jun;23(3):231-5 DOI: 10.1097/ QCO.0b013e32833890e210.1097/QCO.0b013e32833890e220407371Search in Google Scholar

18. Ljostad U, Skogvoll E, Eikeland R, Skarpaas T, et al. Oral doxycycline versus intravenous ceftriaxon for European Lyme neuroborreliosis: a multricentric, non-inferiority, double blind, randomised trial. Lancet Neurol. 2008 Aug;7(8):690-5 DOI: 10.1016/S1474-4422(08)70119-410.1016/S1474-4422(08)70119-4Search in Google Scholar

19. Smith R, Takkinnen J. Lyme borreliosis: Europe-wide coordinated surveillance and action nedeed? Euro Surveill. 2006 Jun;11(6):E060622.110.2807/esw.11.25.02977-en16819127Search in Google Scholar

20. Skogman BH, Glimåker K, Nordwall M, Vrethem M, Ödkvist L, Forsberg P. Long-term clinical outcome after Lyme neuroborreliosis in childhood. Pediatrics. 2012 Aug;130(2):262-9 DOI: 10.1542/peds.2011-371910.1542/peds.2011-371922802606Search in Google Scholar

21. Albrecht P, Henke N, Lehmann HC, Macht S, Hefter H et al. A case of relapsing -remitting neuroborreliosis? Challenges in the differential diagnosis of recurrent myelitis. Case Rep Neurol. 2012 Jan;4(1):47-53 DOI: 10.1159/00033722310.1159/000337223336230222649342Search in Google Scholar

22. Fallon BA, Levin ES, Schweitzer PJ, Hardesty D. Inflammation and central nervous system Lyme disease. Neurobiol Dis. 2010 Mar;37(3):534-41. DOI: 10.1016/j.nbd.2009.11.01610.1016/j.nbd.2009.11.01619944760Search in Google Scholar

23. Wormser GP, Nadelman RB, Schwartz I.The amber theory of Lyme arthritis: initial description and clinical implications. Clin Reumatol. 2012 Jun;31(6):989-94 DOI: 10.1007/s10067-012-1964-x10.1007/s10067-012-1964-x22411576Search in Google Scholar

24. Puius YA, Kalish RA. Lyme arthritis: pathogenesis, clinical presentation, and management. Infect Dis North Am. 2008 Jun;22(2):289-300 DOI: 10.1016/j. idc.2007.12.014Search in Google Scholar

25. Costello JM, Alexander ME, Greco KM, Perez AR, Laussen PC. Lyme carditis in children: presentation, predictive factors, and clinical course. Pediatrics. 2009 May;123(5):835-41 DOI: 10.1542/peds.2008-305810.1542/peds.2008-305819403477Search in Google Scholar

26. Lo R, Meuzies DJ, Archer H, Cohen TJ.J.Complete heart block due to Lyme carditis: Invasive Cardiol. 2003 Jun;15(6):367-9Search in Google Scholar

27. Koene R, Boulware DR, Kemperman M, Konety SH, Groth M, et al. Acute hearth failure from lyme carditis. Circ Heart Fail. 2012 Mar;5(2):e24-6 DOI: 10.1161/ CIRCHEARTFAILURE.111.96553310.1161/CIRCHEARTFAILURE.111.965533331105322438525Search in Google Scholar

eISSN:
2284-5623
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Life Sciences, Molecular Biology, Biochemistry, Human Biology, Microbiology and Virology